News for OraSure Technologies, Inc. (OSUR)

Orasure Technologies trades below liquidation value despite having multiple identifiable catalysts on the horizon. Read why I rate OSUR stock a Buy now.

OraSure Technologies' stock surged 6% after Regeneron's strategic acquisition, strengthening industry ties. Analysts predict a significant upside for Or

Shares of OraSure Technologies (OSUR) experienced a notable increase of 5%, reaching $2.55, following a positive market assessment. This rise comes as Evercore

OraSure Technologies, identified by the ticker OSUR, has entered into a commercial partnership with Targeted Genomics, known for its GlutenID product. This coll

IRVINE, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- Targeted Genomics LLC, developer of GlutenID, the first and only U.S. Food and Drug Administration (FDA) clea

Gain insights into OraSure Technologies' Q1 2025 earnings, highlighting revenue performance, innovation milestones, and strategies to tackle funding...

OraSure Technologies, Inc. (NASDAQ:OSUR) Q1 2025 Earnings Conference Call May 7, 2025 5:00 PM ETCompany ParticipantsJason Plagman - VP of Investor...

OraSure Technologies' strategies to boost growth with cost cuts, a $40M share repurchase, and a focus on higher margins. Read more about OSUR stock here.

BETHLEHEM, Pa., April 23, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. ( OSUR) has scheduled its regular earnings conference call covering first quarte

We recently published a list of 10 Micro-Cap Stocks Insiders Were Buying In Q1 2025. In this article, we are going to take a look at where OraSure Technologies, Inc.

**media[574578]**

On February 28, 2025, [Manner Eglinton](https://www.gurufocus.com/insider/10986/manner-eglinton), President & Chief Executive Officer of OraSure Technologies In

On February 27, 2025, Nancy Gagliano, a Director at OraSure Technologies Inc (OSUR), purchased 12,750 shares of the company. Following this transaction, the ins

On February 27, 2025, Lelio Marmora, a Director at OraSure Technologies Inc, purchased 7,000 shares of the company, as reported in a SEC Filing. Following this

OraSure Technologies, Inc. (NASDAQ:OSUR) Q4 2024 Results Conference Call February 25, 2025 5:00 PM ETCompany ParticipantsJason Plagman - VP of Investor...

Total Revenue: $37.4 million in Q4 2024.Core Revenue: $36.5 million, a 10% year-over-year increase.Diagnostics Revenue: $18.8 million, a 9% year-over-year incr

Feb 25, 2025 / 10:00PM GMTOperator Welcome to the OraSure Technologies Inc 2024 fourth quarter earnings conference call. (Operator Instructions) Please be advis

OraSure (OSUR) delivered earnings and revenue surprises of -200% and 2.27%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Revenue: $37.4 million for Q4 2024, a 51% decrease from $75.9 million in Q4 2023, primarily due to a significant drop in COVID-19 related revenues.Core Revenue